Connection
Amy Ogilvie to Disease Progression
This is a "connection" page, showing publications Amy Ogilvie has written about Disease Progression.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.495 |
|
|
|
-
Schultz JL, Ogilvie AC, Harshman LA, Nopoulos PC. ?-Blocker Use and Delayed Onset and Progression of Huntington Disease. JAMA Neurol. 2025 Jan 01; 82(1):85-92.
Score: 0.136
-
Ogilvie AC, Carnahan RM, Chrischilles EA, Schultz JL. The effects of antidepressants on depressive symptoms in manifest Huntington's disease. J Psychosom Res. 2022 11; 162:111023.
Score: 0.116
-
Ogilvie AC, Nopoulos PC, Schultz JL. Sleep disturbances by disease type and stage in Huntington's disease. Parkinsonism Relat Disord. 2021 10; 91:13-18.
Score: 0.108
-
Ogilvie AC, Nopoulos PC, Schultz JL. Quantifying the Onset of Unintended Weight Loss in Huntington's Disease: A Retrospective Analysis of Enroll-HD. J Huntingtons Dis. 2021; 10(4):485-492.
Score: 0.103
-
Nopoulos S, Reasoner EE, Ogilvie AC, Killoran A, Schultz JL. Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis. Parkinsonism Relat Disord. 2024 Feb; 119:105954.
Score: 0.032